Other NRG1-positive tumor types include pancreatic, gallbladder cancer, renal cell carcinoma, bladder cancer, ovarian cancer, breast cancer, neuroendocrine tumor, sarcoma and CRC, showing how an actionable medication could benefit a large group of patients with a large variety of tumors. The gene discussed is NRG1; the disease is breast cancer.